Carl T D'Angio1, Namasivayam Ambalavanan2, Waldemar A Carlo2, Scott A McDonald3, Kristin Skogstrand4, David M Hougaard4, Seetha Shankaran5, Ronald N Goldberg6, Richard A Ehrenkranz7, Jon E Tyson8, Barbara J Stoll9, Abhik Das10, Rosemary D Higgins11. 1. Strong Children's Research Center, University of Rochester School of Medicine and Dentistry, Rochester, NY. Electronic address: carl_dangio@urmc.rochester.edu. 2. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL. 3. Statistics and Epidemiology Unit, RTI International, Research Triangle Park, NC. 4. Danish Centre for Neonatal Screening, Department of Clinical Biochemistry, Immunology and Genetics, Statens Serum Institut, Copenhagen, Denmark. 5. Department of Pediatrics, Wayne State University, Detroit, MI. 6. Department of Pediatrics, Duke University, Durham, NC. 7. Department of Pediatrics, Yale University School of Medicine, New Haven, CT. 8. Department of Pediatrics, University of Texas Medical School at Houston, Houston, TX. 9. Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA. 10. Statistics and Epidemiology Unit, RTI International, Rockville, MD. 11. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.
Abstract
OBJECTIVE: To explore differences in blood cytokine profiles among distinct bronchopulmonary dysplasia (BPD) patterns. STUDY DESIGN: We evaluated blood spots collected from 943 infants born at ≤1000 g and surviving to 28 days on postnatal days 1, 3, 7, 14, and 21 for 25 cytokines. Infants were assigned to the following lung disease patterns: (1) no lung disease (NLD); (2) respiratory distress syndrome without BPD; (3) classic BPD (persistent exposure to supplemental oxygen until 28 days of age); or (4) atypical BPD (period without supplemental oxygen before 28 days). Median cytokine levels for infants with BPD were compared with the IQR of results among infants with NLD. RESULTS: The distribution of enrolled infants by group was as follows: 69 (NLD), 73 (respiratory distress syndrome), 381 (classic BPD), and 160 (atypical BPD). The remaining 260 infants could not be classified because of missing data (104) or not fitting a predefined pattern (156). Median levels of 3 cytokines (elevated interleukin [IL]-8, matrix metalloproteinase-9; decreased granulocyte macrophage colony-stimulating factor) fell outside the IQR for at least 2 time points in both infants with atypical and classic BPD. Profiles of 7 cytokines (IL-6, IL-10, IL-18, macrophage inflammatory protein-1α, C-reactive protein, brain-derived neurotrophic factor, regulated on activation, normal T cell expressed and secreted) differed between infants with classic and atypical BPD. CONCLUSIONS: Blood cytokine profiles may differ between infants developing classic and atypical BPD. These dissimilarities suggest the possibility that differing mechanisms could explain the varied patterns of pathophysiology of lung disease in extremely premature infants.
OBJECTIVE: To explore differences in blood cytokine profiles among distinct bronchopulmonary dysplasia (BPD) patterns. STUDY DESIGN: We evaluated blood spots collected from 943 infants born at ≤1000 g and surviving to 28 days on postnatal days 1, 3, 7, 14, and 21 for 25 cytokines. Infants were assigned to the following lung disease patterns: (1) no lung disease (NLD); (2) respiratory distress syndrome without BPD; (3) classic BPD (persistent exposure to supplemental oxygen until 28 days of age); or (4) atypical BPD (period without supplemental oxygen before 28 days). Median cytokine levels for infants with BPD were compared with the IQR of results among infants with NLD. RESULTS: The distribution of enrolled infants by group was as follows: 69 (NLD), 73 (respiratory distress syndrome), 381 (classic BPD), and 160 (atypical BPD). The remaining 260 infants could not be classified because of missing data (104) or not fitting a predefined pattern (156). Median levels of 3 cytokines (elevated interleukin [IL]-8, matrix metalloproteinase-9; decreased granulocyte macrophage colony-stimulating factor) fell outside the IQR for at least 2 time points in both infants with atypical and classic BPD. Profiles of 7 cytokines (IL-6, IL-10, IL-18, macrophage inflammatory protein-1α, C-reactive protein, brain-derived neurotrophic factor, regulated on activation, normal T cell expressed and secreted) differed between infants with classic and atypical BPD. CONCLUSIONS: Blood cytokine profiles may differ between infants developing classic and atypical BPD. These dissimilarities suggest the possibility that differing mechanisms could explain the varied patterns of pathophysiology of lung disease in extremely premature infants.
Authors: Waldemar A Carlo; Scott A McDonald; Jon E Tyson; Barbara J Stoll; Richard A Ehrenkranz; Seetha Shankaran; Ronald N Goldberg; Abhik Das; Diana Schendel; Poul Thorsen; Kristin Skogstrand; David M Hougaard; William Oh; Abbot R Laptook; Shahnaz Duara; Avroy A Fanaroff; Edward F Donovan; Sheldon B Korones; David K Stevenson; Lu-Ann Papile; Neil N Finer; T Michael O'Shea; Brenda B Poindexter; Linda L Wright; Namasivayam Ambalavanan; Rosemary D Higgins Journal: J Pediatr Date: 2011-07-27 Impact factor: 4.406
Authors: Richard B Parad; Jonathan M Davis; Jessica Lo; Mark Thomas; Neil Marlow; Sandy Calvert; Janet L Peacock; Anne Greenough Journal: Neonatology Date: 2015-03-03 Impact factor: 4.035
Authors: Rose M Viscardi; Catherine K Muhumuza; Andres Rodriguez; Karen D Fairchild; Chen-Chih J Sun; George W Gross; Andrew B Campbell; P David Wilson; Lisa Hester; Jeffrey D Hasday Journal: Pediatr Res Date: 2004-06 Impact factor: 3.756
Authors: Namasivayam Ambalavanan; Waldemar A Carlo; Carl T D'Angio; Scott A McDonald; Abhik Das; Diana Schendel; Poul Thorsen; Rosemary D Higgins Journal: Pediatrics Date: 2009-04 Impact factor: 7.124
Authors: Joseph M Collaco; Sharon A McGrath-Morrow; Megan Griffiths; Raul Chavez-Valdez; Charlamaine Parkinson; Jie Zhu; Frances J Northington; Ernest M Graham; Allen D Everett Journal: J Pediatr Date: 2022-04-20 Impact factor: 6.314
Authors: Mari Mahlman; Minna K Karjalainen; Johanna M Huusko; Sture Andersson; M Anneli Kari; Outi K T Tammela; Ulla Sankilampi; Liisa Lehtonen; Riitta H Marttila; Dirk Bassler; Christian F Poets; Thierry Lacaze-Masmonteil; Claude Danan; Christophe Delacourt; Aarno Palotie; Louis J Muglia; Pascal M Lavoie; Alice Hadchouel; Mika Rämet; Mikko Hallman Journal: Sci Rep Date: 2017-08-24 Impact factor: 4.379
Authors: Debashis Sahoo; Livia S Zaramela; Gilberto E Hernandez; Uyen Mai; Sahar Taheri; Dharanidhar Dang; Ashley N Stouch; Rachel M Medal; Alyssa M McCoy; Judy L Aschner; Timothy S Blackwell; Karsten Zengler; Lawrence S Prince Journal: Commun Biol Date: 2020-05-22
Authors: Elizabeth Kate Baker; Atul Malhotra; Rebecca Lim; Susan E Jacobs; Stuart B Hooper; Peter G Davis; Euan M Wallace Journal: BMJ Open Date: 2019-03-01 Impact factor: 2.692
Authors: Soumyaroop Bhattacharya; Jared A Mereness; Andrea M Baran; Ravi S Misra; Derick R Peterson; Rita M Ryan; Anne Marie Reynolds; Gloria S Pryhuber; Thomas J Mariani Journal: Front Immunol Date: 2021-01-21 Impact factor: 7.561
Authors: Anum Ali; Ronald Zambrano; Matthew R Duncan; Shaoyi Chen; Shihua Luo; Huijun Yuan; Pingping Chen; Merline Benny; Augusto Schmidt; Karen Young; Nadine Kerr; Juan Pablo de Rivero Vaccari; Robert W Keane; W Dalton Dietrich; Shu Wu Journal: Sci Rep Date: 2021-04-22 Impact factor: 4.379